July 2014 FDA Recall Drug by Wockhardt Usa Inc.
D-1513-2014 - Failed Impurities/Degradation Products

This Class III drug recall was voluntarily initiated by Wockhardt Usa Inc. on July 14, 2014 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation products. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1513-2014

Reason for Recall
Failed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed.
Initiated
07-14-2014
Reported
08-13-2014
Quantity
840 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-count bottle, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA, LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, NDC 64679-101-07.

Batch or Lot Expiration Information

Lot# : DN10635, Exp 01/15; DM13402, DN10247, Exp 11/14; and DM13449, Exp 07/14